Resultados de la búsqueda 61-70 of 8080 for ai透视网格怎么关,图片ai绘画网站,ai智能机器人网站,一站式ai网站,ai写作在线网页版,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This project will investigate whether the analysis of nucleic acids circulating in the blood from tumors can allow real-time monitoring of treatment ...

  2. Neurología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...

  5. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Abemaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    To evaluate the safety of multi-strain probiotic blend in cancer patients receiving ICIs. To evaluate the clinical outcomes related to IIC, including the ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...